Real-time enrollment status for this relapsed/refractory kmt2a-r acute leukemia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:40 AM UTC
| NCT Number | NCT06376162 |
| Recruiting Status | Recruiting |
| Condition | Relapsed/Refractory KMT2A-r Acute Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 11 sites in the US |
| Sponsor | PedAL BCU, LLC |
| Last Updated on CT.gov | October 20, 2025 (Oct 20, 2025) |
As of July 13, 2026: Clinical trial NCT06376162 is currently recruiting participants. This clinical trial study for relapsed/refractory kmt2a-r acute leukemia is actively seeking new participants at 11 locations across the United States. The study is sponsored by PedAL BCU, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06376162 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06376162 was last updated Oct 20, 2025 (October 20, 2025). HelloStudys verifies this status automatically.